Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    IRLAB Therapeutics

    MCap

    SEK653m

    Last close

    SEK14.10

    ▲ 1.50 (11.90%)

    VolitionRx

    MCap

    USD51m

    Last close

    USD0.60

    ▲ 0.05 (9.82%)

    Portobello SpA

    MCap

    EUR12m

    Last close

    EUR2.38

    ▲ 0.20 (9.17%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

bet-at-home – executive interview

bet-at-home – executive interview

bet-at-home — 8 videos in collection

More on this equity

In this interview, CEO Franz Őmer discusses the key highlights of bet-at-home’s FY20 results, which were much better than the company’s guidance (EBITDA of €30.9m versus guidance of €23–27m). In November 2020 management outlined the regulatory changes in Germany and the effect the changes might have on bet-at-home’s results in FY21, so in this interview he provides an update on the company’s view and discusses its new guidance for the year. He then discusses the possibility of regulatory changes in other markets and other potential opportunities that may present themselves. Finally, he discusses the outlook for the dividend in FY21 given the company’s guidance for lower profitability.

< Previous
Next >

You may also be interested in these:

Consumer

bet-at-home - executive interview

Consumer

bet-at-home - executive interview

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free